Myomo, Inc. – Detailed Investor Update: Annual Report Amendment & Key Disclosures

Key Highlights from the 2025 Form 10-K/A Amendment No. 1

• Filing of Amendment No. 1: Myomo, Inc. (NYSE American: MYO) has filed Amendment No. 1 to its Annual Report on Form 10-K (the “10-K/A”) for the fiscal year ended December 31, 2025.
• Purpose of Amendment:
  • To include information previously omitted from the original filing, specifically Part III, Items 10 through 14, as permitted under SEC rules.
  • Correction of typographical errors related to the certification dates for the principal executive and financial officers.
  • Updated certifications from management in compliance with the Sarbanes-Oxley Act, signaling ongoing regulatory compliance.
• Outstanding Shares: As of March 2, 2026, the company reported 38,511,715 shares of common stock outstanding.
• Market Value Disclosure: The aggregate market value of voting and non-voting common stock held by non-affiliates as of June 30, 2025, was disclosed (the precise value was not visible in the excerpt).
• Exchange & Trading: Myomo’s common stock trades under the symbol “MYO” on the NYSE American exchange.

Corporate Governance and Risk Management

• Board Structure: The company maintains multiple committees, including Audit, Compensation, Nominating and Corporate Governance, and Technology, Quality and Regulatory Committees.
  • Each committee has clearly defined oversight roles, including audit, executive compensation, nomination of directors, and oversight of technology and compliance matters.
• Code of Business Conduct and Ethics:
  • Applies to all directors, officers, and employees, reinforcing Myomo’s commitment to ethical conduct, financial integrity, and compliance.
  • Available for review on the company’s website.
• Insider Trading Policy:
  • Strict prohibitions on short sales, derivative transactions, and pledging company securities as collateral by executive officers, directors, and specified employees, unless prior approval is obtained.
  • Designed to prevent trading on material non-public information and avoid alignment issues between management and shareholders.
• Risk Oversight:
  • Management is responsible for daily risk management, while the board (and its committees) maintains oversight, especially regarding financial, operational, and strategic risks.
  • Audit committee plays a lead role in risk oversight and interacts directly with the CFO and external auditors.
• Cybersecurity & Regulatory Compliance: The Technology, Quality and Regulatory Committee reviews management’s cybersecurity efforts, product development, intellectual property portfolio, and compliance with global regulations.

Executive Compensation – Key Details and Potential Shareholder Impact

• Compensation Structure:
  • Compensation for executives includes base salary, annual performance-based bonuses (paid as RSUs for 2025), and long-term equity incentives.
  • 2025 bonuses for the CEO, CFO, and other NEOs ranged from 27% to 52% of base salary, directly tied to performance metrics.
  • RSU grants for 2025 bonuses will be fully vested and their grant dates are set post-10-K/A filing, which may affect dilution and share float in the near future.
• Outstanding Equity Awards: The report includes a detailed breakdown of outstanding equity awards for top executives, including unexercised options and RSUs not yet vested, which could influence future share count and dilution.
• No Timed Disclosures: The company states it did not time the disclosure of material non-public information to affect the value of executive compensation awards.

Other Notable Disclosures

• Shell Company Status: The company confirms it is not a shell company.
• Reporting Compliance: Myomo, Inc. affirms compliance with all SEC reporting requirements, including interactive data file submissions and internal control attestation, though no auditor attestation for internal controls is provided.
• Compensation Recovery: The company has not disclosed any error corrections or restatements requiring recovery of incentive-based compensation under SEC Rule 10D-1.

Price-Sensitive Information and Potential Investor Impact

• Amendment Filing: The filing of Amendment No. 1 itself is not a result of financial restatement or material error correction but is primarily for regulatory compliance and disclosure completeness. This is a neutral to positive signal regarding the company’s governance and transparency.
• Executive Compensation in RSUs: Payment of 2025 bonuses in fully vested RSUs (rather than cash) could affect the share count and future dilution, which shareholders should monitor as it may influence the stock price, especially given the company’s relatively low market capitalization.
• Active Governance & Risk Management: The company’s multiple layers of committee oversight, risk management policies, and strict insider trading policies may appeal to institutional investors and signal robust governance standards.
• Cybersecurity & Regulatory Focus: Ongoing board-level attention to cybersecurity and regulatory compliance reflects responsiveness to evolving risks, which may be viewed positively by the market.

What Investors Should Watch

• Monitor the impact of new RSU grants on share count and potential dilution.
• Stay alert to future filings for updates on compliance, governance, or compensation matters.
• Assess ongoing board and committee effectiveness in oversight, especially in the areas of risk, innovation, and compliance, which are highlighted as priorities.

Disclaimer: This article is a summary and interpretation of Myomo, Inc.’s 2025 Form 10-K/A Amendment No. 1, based on publicly available information. It is intended for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. Investors should review the full SEC filing and consult their financial advisors before making investment decisions.

View MYOMO, INC. Historical chart here